Triple combination for previously untreated advanced non-clear cell kidney cancer
The COSMIC-313 study previously showed improved survival when combining cabozantinib [...]
Bisphosphonates for the treatment of kidney cancer bone metastases
Kidney cancer bone metastases in the long bones of the [...]
Cabozantinib plus atezolizumab in non-clear cell kidney cancer
The results from an extended follow-up of the phase 1b [...]
Triple combination improves survival in patients with advanced kidney cancer
Results from the phase 3 COSMIC-313 trial showed that adding [...]
CAR T-cell therapy shows promise for the treatment of advanced kidney cancer
CAR T-cell therapy is a type of immunotherapy. It is [...]
Brain metastases from kidney cancer treated with first-line therapies
A recent study looked at the outcomes of patients with [...]
Belzutifan plus cabozantinib combination shows promising results in kidney cancer
Kidney cancers often have mutations in a gene called the [...]
Savolitinib and durvalumab for metastatic papillary kidney cancer
In a phase 2 clinical trial, patients with metastatic papillary [...]
Adjuvant nivolumab plus ipilimumab for localised kidney cancer
In this randomised phase 3 trial, the effectiveness and safety [...]
Fat loss may result in worse outcomes for patients treated with immunotherapy for metastatic kidney cancer
A recent study presented at the Annual Congress of the [...]
